
Bharat Biotech to launch Hillchol, its oral cholera vaccine, amid a global shortage. With Phase III trials completed and 200M…
IHH’s NTK arm raises damages claim to Rs 11,800 crore against Daiichi Sankyo, alleging obstruction in Fortis Healthcare acquisition. Based…
Govt invites fresh applications under the PLI scheme to boost bulk drug production. Focus on 11 key APIs, KSMs, and…
Dinesh Madhavan, President – Group Oncology & International at Apollo Hospitals, emphasized that India’s healthcare system needs preventive vaccination; enforcement…
Investors are closely monitoring the performance of Indian pharma companies in the March 2025 quarter and their ability to grow…
Pharma stocks rise amid market drop due to limited impact from US pricing order. Discover more on what fuels this…
Trump’s previous attempt to implement international reference pricing during his first term was blocked in court, though it was estimated…
Nifty Pharma share price today, May 12: Pharma stocks fall as Trump plans to slash US drug prices. Discover more…
The pharma stocks in India see significant selloff after US President Donald Trump signs executive orders promoting active and faster…
The proposed merger between Suven Pharmaceuticals and Cohance Lifesciences will be effective from May 1, 2025. Suven Pharmaceuticals said that…
Indian pharma firms eye full exemption from US reciprocal tariffs amid a 90-day breather, citing America’s heavy reliance on affordable…
India Plans Logistics Overhaul for Pharma and Medical Devices Amid US Tariff Concerns. Even as the pharma industry navigates potential…
Healthcare costs in India are expected to rise by 13% in 2025, surpassing the global average of 10% and the…
Emcure Pharmaceuticals acquires UK-based Manx Healthcare for £19.7 million, expanding its portfolio in generics and OTC products. The company also…
India’s pharmaceutical sector benefits from the US excluding it from reciprocal tariffs, securing affordable medicines. However, medical device exports face…
In FY24, Indian pharmaceutical exports to the U.S. were valued at approximately USD 8 billion, with the industry witnessing an…
According to analytics firm IQVIA, Indian generics saved the US healthcare system $219 billion in 2022 and $1.3 trillion between…
IgAN is a progressive, rare kidney disease in which the immune system attacks the kidneys, often causing glomerular inflammation and…
North Korean leader Kim Jong Un said there is no reason to avoid dialogue with the US if Washington stops insisting that Pyongyang give up its nuclear weapons. Kim made it clear his country will never trade its arsenal for relief from sanctions, state media reported on Monday.